ScienceDaily: All - November 02, 2023
Today's top research news
Hebrew prayer book fills gap in Italian earthquake history
The chance discovery of a note written in a 15th century Hebrew prayer book fills an important gap in the historical Italian earthquake record, offering a brief glimpse of a previously unknown earthquake affecting the Marche region in the central Apennines.
In a surprising finding, light can make water evaporate without heat
At the interface of water and air, light can, in certain conditions, bring about evaporation without the need for heat, according to a new study.
TakumiRL/shutterstock.com
What happens when we pass out? Researchers ID new brain and heart connections
Researchers have for the first time identified the genetic pathway between the heart and brain tied to fainting. They found that vagal sensory neurons trigger fainting, laying a foundation for addressing fainting-related disorders.
Giant dinosaur carcasses might have been important food sources for Jurassic predators
Carnivorous dinosaurs might have evolved to take advantage of giant carcasses, according to a new study.
What happens when cats get fat? Scientists weigh in
Cat owners want Kitty to be happy, but providing an abundance of food and snacks can have unintended consequences. Feline obesity is on the rise, impacting the health, longevity, and wellbeing of cats. A new study looks at what happens in the digestive system and gut microbiota when cats eat too much.
Researchers examine the relationship between loneliness and being alone
A new study finds that solitary time does not closely correlate with feelings of loneliness -- unless a person spends 75% of their time alone.
Chemists make breakthrough in drug discovery chemistry
Chemists offer two new methods to develop a way to easily replace a carbon atom with a nitrogen atom in a molecule. The findings could make it easier to develop new drugs.
Repurposed drug offers new potential for managing type 1 diabetes
A new study presents exciting future possibilities for the management of type 1 diabetes and the potential reduction of insulin dependency. The study's findings suggest repurposing of the drug alpha-difluoromethylornithine (DFMO) may open doors to innovative therapies in the future.
First mice engineered to survive COVID-19 like young, healthy humans
Researchers have genetically engineered the first mice that get a human-like form of COVID-19, according to a new study.